Labs / CDMO: development & manufacturing
VIVEbiotech
Donostia-San Sebastian, Spain · vivebiotech.com
GMP · ISO 9001
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
VIVEbiotech is a CDMO in Donostia / San Sebastian, Spain that develops and manufactures GMP lentiviral vectors. It serves biotech and pharmaceutical companies worldwide for ex vivo and in vivo gene and cell therapy programs.
They take quote requests by email.
What they offer
Early-phase development
Development adapted to the requirements of each lentiviral vector project.
Cloning activities
Cloning from design to cloning aimed at increasing productivity and meeting regulatory requirements.
Process optimization
Optimization activities including producer cell line adaptation, transfection adjustments, and pseudotyping strategies.
R&D manufacture in 2D format
R&D-scale manufacturing in 2D format.
R&D manufacture in bioreactors
R&D-scale manufacturing in bioreactors.
Engineering batches
Manufacture of engineering batches for preclinical phases.
GMP batches
Manufacture of GMP batches for clinical and commercial phases.
Batch release
Batch release by the company’s own Qualified Person.
Stability studies
Long-term and in-use stability studies.
Regulatory support
Support for CMC sections of IMPD and IND dossiers.
Outsourced partner management
Management of outsourced partners such as analytical testing and plasmid manufacturing.
What they work on
- Modalities
- Viral vector, Cell therapy, Plasmid DNA
- Species and models
- VSV-G pseudotyped lentiviral vectors, producer cell lines, stable producer cell lines, monoclonal packaging cell line
- Assays and studies
- stability studies, potency assays, analytical methods for batch release, yield assessment, clone screening
- Instruments and platforms
- bioreactors
- Scale and capacity
- 7 dedicated cleanrooms, +200 batches manufactured in bioreactor, +60 batches in reactor per year, GMP batches for clinical and commercial phases
- Therapeutic areas
- haematological cancers, solid cancers, rare diseases, solid tumours
- Turnaround
- prototype cell line in three months
- Type
- CRDMO
- Sites
- Donostia · San Sebastian, Spain
- Team
- +150 people
- Quality
- EMA (regulatory requirements) · FDA (regulatory requirements) · UNE – EN ISO 9001-2008 · GMP certification for clinical-grade rel
- Serves
- US, Europe, Asia, Australia
- Founded
- 2015
Public records
- Ownership
- VIVEBIOTECH SL · ES GLEIF
Similar labs. Minaris, AGC Biologics, Artis, Asimov
Found in a contract services directory. Listing built from vivebiotech.com. Work here? Claim this listing.